Call us: 1-737-802-1977

Lung Therapeutics, Inc. is a pharmaceutical company targeting niche, orphan drug indications for lung injury and disease, with an emphasis on fibrosis.

Targeting unmet clinical needs in lung injury and disease.

Bringing hope to patients with fibrotic disease and lung injury

Now Hiring - Join us in making an impact on lung injury and disease

Improving clinical pathways for loculated pleural effusion

Lung Disease

Lung disease includes a range of illnesses such as asthma, bronchitis, chronic obstructive pulmonary disease (COPD), pneumonia, lung cancer, cystic fibrosis, and other complications related to these illnesses.

Read More

Programs

Lung Therapeutics currently has a number of programs underway. These are all associated with various types of fibrosis for which LTI discoveries hold promise for new therapies.

Read More

Research

Research led by Founder and Chief Scientific Officer, Dr. Steven Idell, M.D., Ph.D., includes more than 25 years of funded efforts in the areas of lung injury and disease.

Read More

Respiratory Disease States

  • Pleural Effusion
  • Acute Lung Injury
  • Idiopathic Pulmonary Fibrosis

Pleural Effusion (PE) is defined by fluid buildup surrounding the lungs in the pleural cavity. This excess fluid may cause chest pain and shortness of breath, reducing the lung's capacity for expansion and for oxygenating the blood.  More >

Acute Lung Injury (ALI) describes a number of clinical symptoms and syndromes with significant morbidity and mortality. The disease is characterized by hypoxemia and diffuse pulmonary infiltrates. In early phase acute lung injury, edema fluid leaks into the lungs due to endothelial and epithelial injury along with inflammatory infiltrates, resulting in reduced lung compliance.  More >

Idiopathic Pulmonary Fibrosis (IPF) is defined as scar tissue of the lungs from unknown causes, perhaps deriving genetically or in response to disease or injury. The condition results in poor efficiency in the lungs, either in passively exchanging oxygen and carbon dioxide or in fully expanding to draw in air.  More >